Arkolith/Insider Trading/SER/Form 4

Wilson Karen J

DirectorSerina Therapeutics, Inc. (SER) · full profile →Form 4 · filed Jun 15, 2026
Net Buying
Open-Market Buys
$18K
Open-Market Sells
$0
Net Open-Market Flow
$18K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 12, 2026Buy(P)5K$1.77$9K10K
Jun 11, 2026Buy(P)5K$1.75$9K5K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001267490-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML